Delivery Order SPE2DR25D2101-SPE2DR26F46AA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of esomeprazole magnesium delayed-release 40 mg capsules (30-count) with a ceiling value of $1,130.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units) valued at $1,066.56. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count units) with a ceiling value of $3,199.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) at a ceiling value of $1,030.76. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a firm fixed price ceiling value of $5,752.28. The award was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive delivery order, which carries no set-aside designation, represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a ceiling value of $1,907.60. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a ceiling value of $6,153.50. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count unit) with a ceiling value of $3,734.00. This firm fixed-price delivery order is scheduled for completion by October 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count) at a firm fixed price of $1,928.75, with an ultimate completion date of August 20, 2025. This is a non-set-aside, competitively awarded contract, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $1,609.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 40 mg capsules (30-count supply) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46AADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units) with a ceiling value of $1,032.48. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by December 2, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical prime vendor contract running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and military medical supply chains. The company maintains an extensive portfolio of pharmaceutical products and medical supplies spanning multiple therapeutic domains, from specialty medications and vaccines to generic drugs and medical devices. This particular delivery order for esomeprazole, a proton pump inhibitor used in gastric acid management, exemplifies the routine pharmaceutical procurement conducted under the company's prime vendor agreement to support military and federal healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/30/25 |